AI assistant
Sending…
ABBOTT LABORATORIES — Director's Dealing 2005
Jan 25, 2005
29777_dirs_2005-01-25_68c48455-ab57-4c24-b1e4-7bb0d85dcabd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2004-12-16
Reporting Person: NEMMERS JOSEPH M (Senior Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2004-12-16 | Common shares without par value | G | 1609 | — | Disposed | 61958 | Direct |
| 2005-01-21 | Common shares without par value | S | 8728 | $45.8476 | Disposed | 53230 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common shares without par value | 10583 | Indirect |
| Common shares without par value | 338 | Indirect |
| Common shares without par value | 338 | Indirect |
| Common shares without par value | 278 | Indirect |
| Common shares without par value | 284 | Indirect |
Footnotes
F1: Balance in the Abbott Laboratories Stock Retirement Trust as of January 21, 2005.
F2: Reporting person disclaims beneficial ownership of all securities held by his sons.
F3: Includes shares acquired under the Abbott Laboratories Dividend Investment and Stock Purchase Plan in transactions exempt from Section 16(b) under Rule 16(a)-11.
More from ABBOTT LABORATORIES
Regulatory Filings
2026
May 27
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 29
Regulatory Filings
2026
Apr 27
Regulatory Filings
2026
Apr 24
Legal Proceedings Report
2026
Apr 17
Earnings Release
2026
Apr 16
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 25